Viewing Study NCT04434534


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-01 @ 5:36 AM
Study NCT ID: NCT04434534
Status: UNKNOWN
Last Update Posted: 2020-06-17
First Post: 2020-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Açaí Juçara Consumption on Endothelial Function and Arterial Stiffness
Sponsor: Instituto de Cardiologia do Rio Grande do Sul
Organization:

Study Overview

Official Title: Effect of Açaí Juçara Consumption on Endothelial Function and Arterial Stiffness in Overwheight or Obese Individuals: A Randomized Clinical Trial
Status: UNKNOWN
Status Verified Date: 2020-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study evaluates the consumption of Açaí Juçara pulp in endothelial function and arterial stiffness in overwheight and obese individuals. Half of participants will receive a hipocaloric diet and two Açaí Juçara pulps for daily consumption, while the other half will receive just a hipocaloric diet.
Detailed Description: Obesity is the most prevalent nutritional disease and a growing public health problem worldwide. This clinical condition is an established risk factor for cardiovascular diseases.

Açaí Juçara is a brazilian fruit, rich in antioxidants, like anthocyanin. This compound have antioxidative and vasodilatory properties. Prospective studies have shown that the antioxidant present in berries can improve vascular health, like endothelial function, measured by Flow Mediated Dilatation (FMD) and arterial stiffness, measured by Pulse Wave Velocity (PWV).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: